Search alternatives:
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e point » _ point (Expand Search), 5 point (Expand Search), a point (Expand Search)
-
1181
-
1182
Retinoschisin secretion into the conditioned medium is decreased by addition of cytochalasin D.
Published 2013“…(D) Retinoschisin secretion decreases in a dose-dependent manner by treatment of cells with cytochalasin D at concentrations between 0.5 µM and 2 µM. …”
-
1183
-
1184
Vasopressin decreases EPSPs in CA2 after LTP induction.
Published 2013“…Values are expressed as % of the mean of the responses recorded during 5 min before AVP application. …”
-
1185
SPL decreases diabetes-induced oxidative stress in GL and PT.
Published 2017“…Similar results were found between CTL and SPL groups. Data are mean±SEM from 5–6 rats per group. *p<0.05; **p<0.01 and ***p<0.001.…”
-
1186
-
1187
-
1188
-
1189
-
1190
PE activity and a decreasing degree of pectin methyl-esterification were specific to pericarp tissues.
Published 2013“…One unit means a decrease in OD<sub>620</sub> per second. …”
-
1191
-
1192
The expression of genes related to mitochondria was decreased in Pgam2 mice.
Published 2013“…NRF-1: nuclear respiratory factor 1; CD36/FAT: CD36/fatty acid translocase; MCAD: medium-chain acyl coenzyme A dehydrogenase; Cox5a: mitochondrial cytochrome c oxidase subunit Va. …”
-
1193
-
1194
-
1195
-
1196
-
1197
-
1198
-
1199
-
1200
Acute JMV2959 treatment decreases alcohol preference in rats.
Published 2013“…<p>(A) Acute administration of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) decreases the alcohol preference compared to vehicle at 1 hour time interval in rats voluntarily consuming alcohol for two and five months before the treatment. …”